-
Services
- High Throughput Antibody Production
- High Throughput Antibody Production assist Phage Display based Lead Discovery
- High Throughput Antibody Production assist Single B Cell Sorting based Lead Discovery
- High Throughput Antibody Production assist AI-driven Lead Discovery
- High Throughput Antibody Production assist Hybridoma & Antibody Sequencing based Lead Discovery
- High Throughput Antibody Production assist Transgenic Mice based Lead Discovery
- Custom Antibody Production & QC
- Prokaryotic System based Antibody Production & QC
- Eukaryotic System based Antibody Production & QC
- Antibody Fragment Production & QC
- Antibody Production & QC with Cell-Free Systems
- IgA Engineering & Production
- Rare Species derived Antibody Production & QC
- Light-based Antibody Purification
- Functional Antibody Production & QC
- Engineered Antibody Production & QC
- Antibody Derivative Development
- Bispecific Antibody Development
- Antibody-Drug Conjugate Development
- Glycoprotein Glycosylation Analysis
- BCR Production & QC
- Soluble TCR Production & QC
- OmicsMab™ Proteome Scale Antibody Discovery
- Antibody-based Active Targeting System
- Antibody Quality Assessment
- High Concentration Antibody Production
- High Throughput Antibody Production
Genetic Engineering Service
With extensive experience in antibody engineering and recombinant monoclonal antibody manufacturing, Creative Biolabs now provides the custom genetic engineered bispecific antibody development service, enabling clients to adjust the format, size, valency, flexibility and half-life of bispecific antibody (BsAb) to achieve the desired BsAb profile.
Our experts are committed to offering the most suitable strategy to meet the needs of each customer. To design the specific BsAb, we use the elegant “knobs-into-holes” technique as well as the appropriate linkers and VH/VL domains orientation to promote the formation of BsAb molecules correctly; for expression of the desired BsAbs, a series of different vectors and expression systems (mammalian and microbial systems) are available.
To take the advantage of state-of-the-art facilities and the mature genetic engineering technology, Creative Biolabs has established a low-cost, high-yield and time-efficient BsAb development platform with the capability of generating multiple bispecific antibodies for both academic and industrial purposes.
The main procedures for developing BsAbs by using genetic engineering include:
- Molecular design, including the design of an optimal linker and VH/VL domains orientation
- Stable cell lines construction, including the generation of high expression vectors and high-yield and stable cell lines
- Scale-up production, purification and characterization
We offer a full range of techniques approaches needed for bispecific antibody development:
- Genetic Engineering
- Chemical Conjugation
- Hybrid–hybridoma Technology
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
